BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2013
View Archived Issues
Novel CKId inhibitors show significant improvement in spatial memory in vivo
Read More
Researchers develop novel animal models of pediatric OP-induced SE
Read More
Alda-1 exerts protective effect against neuronal death in HE
Read More
uniQure develops novel gene therapies for HD
Read More
VASH1 as a biomarker of prognosis in RCC
Read More
Novel shRNA designed for Huntington's disease
Read More
Data presented from clinical study of NewGam IVIG in MCI
Read More
BioChaperone PDGF-BB to enter phase III development
Read More
Omeros identifies mechanism of action of its PDE7 inhibitors in addiction
Read More
Soligenix updates on ThermoVax vaccine thermostabilization technology
Read More
UCB and Five Prime Therapeutics enter collaboration
Read More
FDA recategorizes Meridian's illumigene tests for Streptococcus
Read More
Focus on carbapenem-resistant Enterobacteriaceae: need for action
Read More
Millennium Pharmaceutical presents new agents for cancer
Read More
Scientists at Bayer disclose novel BRD4 ligands
Read More
Amakem prepares new ROCK inhibitors
Read More
Otsuka Pharmaceutical divulges novel agents for bacterial infections
Read More
Hybrigenics synthesizes new USP7 inhibitors
Read More
Purdue Pharma discloses new Na(v)1.7 blockers
Read More
Biotron announces preliminary results from human trial of BIT-225
Read More
Novo Nordisk completes phase I study of new oral insulin
Read More
Acasti Pharma reports preliminary data from CaPre trial
Read More
First patients dosed in proof-of-concept trial of ALD-403
Read More
NX-1207 trial receives third positive safety review
Read More
BioMarin reports phase I/II data for BMN-701 in Pompe's disease
Read More
Merrimack Pharmaceuticals completes enrollment in a phase II study of MM-121
Read More
Pluristem Therapeutics gives update on study of PLX cells in muscle injury
Read More
BioLineRx to discontinue CLARITY trial following interim analysis
Read More